We wish to inform that the 01st Extra-Ordinary General Meeting ("EGM") of the Company was held on Thursday, April 02, 2026 at 12:00 P.M. (IST), through Video Conferencing ("VC") / Other ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Covidh Technologies Ltd held its 1st Extra-Ordinary General Meeting on April 2, 2026, via video conferencing, where all 5 resolutions were passed. The key resolution is a special resolution to change the company's name from 'Covidh Technologies Limited' to 'iSERA Lifesciences Limited', along with corresponding changes to the MOA and AOA. Additionally, 4 directors were appointed: Mr. Dhairyasheel Vasantrao Yadav and Mr. Nandkumar Subhash Kadam as Executive Directors, and Mr. Pratap Dadasaheb Deshmukh and Ms. Ritu Dhanraj Garad as Non-Executive, Non-Independent Directors. Out of 1,052 shareholders holding 84.09 lakh shares total, only 25 shareholders voted representing 15.35 lakh shares — a low turnout of just 18.25%. However, all voted resolutions received 100% approval with zero votes against, including the special resolution which requires a higher majority threshold.
The unanimous approval of the name change to 'iSERA Lifesciences' suggests a strategic pivot toward the life sciences and pharmaceutical sector, which could be positive for future business direction. The appointment of four new directors, including two executive directors, signals a management restructuring likely tied to the rebrand. However, the very low 18.25% voting turnout and the fact that only 25 shareholders participated means retail investors should monitor upcoming developments closely, as the name change and new leadership could materially alter the company's business profile.